Studieoverzicht
BOOG nr.: |
Status: ( View all )
|
Indication: ( View all )
|
Subindication: |
Menopausal status: |
2022-04 NABOR | Open | Data registration | Any HER2, any HR | Both pre- and postmenopausal | ||||||||||||||
2022-02 DESCARTES | Open | Locoregional | Any HER2, any HR | Both pre- and postmenopausal | ||||||||||||||
2010-05 SUBMIT | Closed | Advanced/metastatic | Any HER2, any HR | Both pre- and postmenopausal | ||||||||||||||
2010-04 D-Care | Follow up | Adjuvant | Any HER2, any HR | Both pre- and postmenopausal | ||||||||||||||
2008-02 A6181099 | Closed | Advanced/metastatic | Any HER2, any HR | Both pre- and postmenopausal | ||||||||||||||
2008-01 2-2-6 G-CSF | Closed | Adjuvant | Any HER2, any HR | Both pre- and postmenopausal | ||||||||||||||
2007-02 INTENS | Closed | Neoadjuvant | Any HER2, any HR | Both pre- and postmenopausal | ||||||||||||||
2006-02 OMEGA | Closed | Advanced/metastatic | Any HER2, any HR | Postmenopausal | ||||||||||||||
2005-03 MINDACT | Follow up | Adjuvant | Any HER2, any HR | Both pre- and postmenopausal | ||||||||||||||
2005-02 MATADOR | Follow up | Adjuvant | Any HER2, any HR | Both pre- and postmenopausal | ||||||||||||||
2003-04 Pregnancy | Follow up | Not applicable | Any HER2, any HR | Premenopausal | ||||||||||||||
2003-02 Calor | Closed | Adjuvant | Any HER2, any HR | Both pre- and postmenopausal |